TLSA Latest Press Releases

-- November 2, 2026 --

Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Globe Newswire 7:00 AM

-- October 21, 2026 --

Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto Globe Newswire 7:00 AM

-- October 16, 2026 --

Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer's Disease Globe Newswire 7:00 AM

-- September 30, 2026 --

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA) Globe Newswire 7:00 AM

-- September 28, 2026 --

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab Globe Newswire 7:00 AM

-- September 21, 2026 --

Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab Globe Newswire 7:00 AM

-- September 17, 2026 --

Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center Globe Newswire 7:00 AM

-- August 24, 2026 --

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026 Globe Newswire 7:00 AM

-- August 4, 2026 --

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer Globe Newswire 7:00 AM

-- July 31, 2026 --

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab Globe Newswire 7:00 AM

-- July 22, 2026 --

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman Globe Newswire 7:00 AM

-- June 25, 2026 --

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial Globe Newswire 7:00 AM

-- June 15, 2026 --

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes